CDT
CDT Equity Inc.
Key Financials
Operating Income
$-36757000
↓ 138.4%
Net Income
$-39224000
↓ 120.3%
Total Liabilities
$12.8M
↑ 16.7%
Total Assets
$5.7M
↑ 34.7%
Shareholders' Equity
$-7170000.00
↓ 5.5%
EPS (Diluted)
$-1177.89
↓ 5637.4%
Cash & Equivalents
$1.5M
↑ 172.4%
Operating Cash Flow
$-15555000.00
↓ 60.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| SCHEDULE 13D/A | 5/14/2026 | View on SEC |
| 4 | 5/14/2026 | View on SEC |
| EFFECT | 5/1/2026 | View on SEC |
| 424B3 | 5/1/2026 | View on SEC |
| 3 | 4/30/2026 | View on SEC |
| 8-K | 4/27/2026 | View on SEC |
| S-3 | 4/22/2026 | View on SEC |
| 10-K | 4/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CDT |
| Company Name | CDT Equity Inc. |
| CIK | 1896212 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (646) 491 9132 |